Aloxi (Palonosetron)

Palonosetron is a medicine used to help prevent nausea and vomiting. It's often given before or after certain types of cancer treatments or surgery to stop sickness. It works by blocking a specific type of nerve signal that causes these feelings.

Brand names:Aloxi
Medication

What people taking Aloxi (Palonosetron) report

Every report comes from a Lived member, sent anonymously.

Have you tried Aloxi (Palonosetron) for Nausea?

NameHow it went

About Aloxi (Palonosetron)

What It's For

Palonosetron is an anti-nausea medicine given into a vein to prevent the nausea and vomiting that cancer chemotherapy and surgery can cause. It was long sold under the brand name Aloxi, which is no longer on the US market; today it is given as generic palonosetron or under the brand Posfrea. It belongs to a group of medicines called 5-HT3 (serotonin type 3) receptor antagonists, which also includes ondansetron and granisetron. In adults, it is approved to prevent nausea and vomiting from chemotherapy. With moderately emetogenic chemotherapy (treatments that often, but not always, cause nausea), it is approved for both the first day and the delayed days that follow. With highly emetogenic chemotherapy, the treatments most likely to cause vomiting, such as cisplatin, it is approved for the first day and is combined with other anti-nausea medicines to cover the days after. It is also approved in adults to prevent nausea and vomiting for up to 24 hours after surgery, and in children from 1 month to under 17 years to prevent nausea on the day of chemotherapy. Palonosetron is also one of the two ingredients in Akynzeo, a combination with netupitant (or fosnetupitant in the IV form), a medicine that blocks a different nausea pathway. Akynzeo has its own instructions; this page is about palonosetron on its own.

How It Works

Many chemotherapy drugs cause cells in the lining of the small intestine to release serotonin. That serotonin acts on 5-HT3 receptors on the vagus nerve, which carries signals from the gut to the brain, and on a part of the brainstem that triggers vomiting. Palonosetron attaches to those receptors and blocks them, which weakens the signal to vomit. Nausea after surgery has several causes, including anesthesia and the operation itself, and serotonin signaling is one of them. Palonosetron binds tightly to its receptor and leaves the body slowly: on average, half of a dose is still present about 40 hours later. That is why a single dose before treatment is the standard approach. Because it blocks only one of the pathways behind nausea, it is usually paired with dexamethasone, a steroid, and for the most nausea-causing chemotherapy, with a medicine from a third class called NK1 (neurokinin-1) receptor antagonists, such as aprepitant, which block a separate nausea signal called substance P.

Dosage & Administration

Palonosetron is not a medicine people take at home. A nurse or doctor gives it as a single dose through an IV (intravenous) line in a hospital, clinic or infusion center. Before chemotherapy, adults usually receive it about 30 minutes before treatment starts, as a quick injection over about 30 seconds. Children receive a dose based on body weight, given over about 15 minutes. Before surgery, adults receive a smaller dose just before anesthesia begins. It is given once per chemotherapy cycle or once before an operation, not as a daily medicine. Ask the care team what to take at home if nausea returns in the following days, and how to take it.

Side Effects

Most people notice little from palonosetron itself. In chemotherapy trials, headache (about 9 in 100 people) and constipation (about 5 in 100) were the most common effects, and side effects overall were about as common as with ondansetron. Pain or discoloration where the IV goes in has been reported rarely. After surgery, a slow heart rate and a change on the heart tracing called QT prolongation (a delay in the heart's electrical recovery between beats) were reported in a small share of people, about as often as with a placebo. Tell the care team about fainting or a fast, slow or irregular heartbeat. Allergic reactions, including anaphylaxis (a severe, whole-body allergic reaction), are rare but have been reported. Tell the staff at once about itching, hives or trouble breathing during treatment. If trouble breathing or swallowing, or swelling of the face or throat, starts after you have left, call 911. Serotonin syndrome, a reaction to too much serotonin activity, is also rare but can be serious. Signs include agitation or confusion, a racing heart, sweating or fever, shaking, stiff or twitching muscles and loss of coordination. Contact the care team right away if these appear. A seizure or loss of consciousness needs emergency care.

Interactions & Warnings

The main interaction concern is serotonin syndrome. It has been reported with 5-HT3 blockers alone, but most cases involved people also receiving other drugs that increase serotonin activity, and some were fatal. These include SSRI and SNRI antidepressants (selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors) such as sertraline or duloxetine, MAO (monoamine oxidase) inhibitors, an older class of antidepressants, mirtazapine (another antidepressant), lithium (a mood stabilizer), fentanyl and tramadol (opioid pain medicines) and intravenous methylene blue (a hospital medicine given by IV to treat a blood problem that keeps red blood cells from carrying oxygen). Most reported cases happened in recovery rooms or infusion centers, where several of these drugs are often given close together. The label calls for monitoring rather than avoiding these combinations, so the important step is making sure the care team has a complete medication list. Palonosetron should not be given to anyone who has had an allergic reaction to it. Reactions have occurred both in people with and without a past allergy to related drugs such as ondansetron or granisetron, so mention any earlier reaction to an anti-nausea medicine. There are no data on palonosetron in human pregnancy; animal studies did not show harm to the developing fetus. It is not known whether it passes into breast milk. Anyone who is pregnant or breastfeeding can weigh this with the care team.

What to Expect

Palonosetron is given before nausea starts because its job is prevention. It reduces nausea and vomiting for many people but does not eliminate them for everyone, and results vary with the type of chemotherapy and the person. With highly nausea-causing chemotherapy, it covers the first day; the second to fifth days depend on the other medicines in the plan, such as dexamethasone or an NK1 receptor antagonist. After surgery, a single dose covers the first 24 hours and has not been shown to help beyond that. In the studies that led to its approval, a single dose of palonosetron prevented first-day nausea and vomiting about as well as older 5-HT3 blockers such as ondansetron; it has not been shown to be better for that first day. With moderately nausea-causing chemotherapy, the same single dose also helped prevent nausea and vomiting over the following four days. Whether palonosetron works better than an older 5-HT3 blocker when both are given with dexamethasone is uncertain, and for the most nausea-causing chemotherapy, large reviews have not found one clearly best combination. Nausea and vomiting are worth reporting even when they feel manageable. They are among the most common and distressing side effects of cancer treatment, and the plan for the next cycle can often be strengthened.

Questions to Ask Your Doctor

  1. 1.Why is palonosetron part of my plan rather than ondansetron or granisetron, and what else is in my anti-nausea regimen?
  2. 2.What should I take at home if nausea starts on the second or third day after treatment?
  3. 3.Could any of my current medicines, such as an antidepressant or pain medicine, raise my risk of serotonin syndrome?
  4. 4.If I still have nausea or vomiting this cycle, how would we change the plan for the next one?

Last reviewed • Oct 2026

Educational content, not medical advice.